Tagged with Investment,

Esteve’s Staffan Schüberg on Mid-Cap Innovation, Generics Divestment & Growth Foundations
Staffan Schüberg – CEO, Esteve
Robert Fabregat – CEO, Biocat
Toni Andreu – Scientific Director, European Infrastructure for Translational Medicine (EATRIS)
Top Biotech VC Investors 2021
Javier Urzay – Subdirector General, Farmaindustria, Spain
Vall d’Hebron: A One-Stop-Shop for Breakthrough Innovation in Catalonia?
Judit Anido – CEO, CataloniaBio & HealthTech
Egypt Pharma News: Healthcare Service Expansion, Omicron Threat, Medical Tourism Boost
J.P. Morgan Healthcare Conference 2022: Glass Half Full
5 Things to Know about the Life Sciences in Catalonia
Top 4 Priorities for Turkey’s Minister of Health
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here